Excelsior Biopharma Inc. (TPEX:6496)

Market Cap	1.35B
Revenue (ttm)	859.77M
Net Income (ttm)	-165.68M
Shares Out	46.75M
EPS (ttm)	-3.59
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,592
Average Volume	41,990
Open	29.20
Previous Close	28.80
Day's Range	28.65 - 29.20
52-Week Range	21.55 - 35.35
Beta	-0.03
RSI	40.46
Earnings Date	Feb 11, 2026

About Excelsior Biopharma

Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers prescription drugs, over-the-counter drugs, medical devices, healthcare food products, medical supplies, and other products. The company provides its products for the therapeutic areas, such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, and otorhinolaryngology, as well as infectious diseases. It also offers test kits under the Actim name to de...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6496

Financial Performance

In 2024, Excelsior Biopharma's revenue was 861.91 million, an increase of 11.71% compared to the previous year's 771.56 million. Losses were -98.71 million, 8.45% more than in 2023.